Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Edington

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2bWenjun Wang, Howard D Edington, Uma N M Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responsesStergios J Moschos, Howard D Edington, Stephanie R Land, et al.
The American Journal of Physiology|October 12, 1999
Impaired wound healing and angiogenesis in eNOS-deficient miceP C Lee, A N Salyapongse, G A Bragdon, et al.
The Journal of Investigative Dermatology|February 29, 2008
STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapyWenjun Wang, Howard D Edington, Uma N M Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2bZoya R Yurkovetsky, John M Kirkwood, Howard D Edington, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|September 1, 1990
Bowel function of long-term tube-fed patients consuming formulae with and without dietary fiberK Shankardass, S Chuchmach, K Chelswick, et al.
Oncogene|February 14, 2007
SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomasS J Moschos, A P Smith, M Mandic, et al.
Journal for Immunotherapy of Cancer|April 21, 2016
Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancerMichal Radomski, Herbert J Zeh, Howard D Edington, et al.
Cancer|June 28, 2000
Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanomaJ M Kirkwood, R A Mascari, H D Edington, et al.
Molecular Medicine (Cambridge, Mass.)|March 11, 1999
Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesionsJ M Kirkwood, D L Farkas, A Chakraborty, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2bWenjun Wang, Howard D Edington, Uma N M Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responsesStergios J Moschos, Howard D Edington, Stephanie R Land, et al.
The American Journal of Physiology|October 12, 1999
Impaired wound healing and angiogenesis in eNOS-deficient miceP C Lee, A N Salyapongse, G A Bragdon, et al.
The Journal of Investigative Dermatology|February 29, 2008
STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapyWenjun Wang, Howard D Edington, Uma N M Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2bZoya R Yurkovetsky, John M Kirkwood, Howard D Edington, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|September 1, 1990
Bowel function of long-term tube-fed patients consuming formulae with and without dietary fiberK Shankardass, S Chuchmach, K Chelswick, et al.
Oncogene|February 14, 2007
SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomasS J Moschos, A P Smith, M Mandic, et al.
Journal for Immunotherapy of Cancer|April 21, 2016
Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancerMichal Radomski, Herbert J Zeh, Howard D Edington, et al.
Cancer|June 28, 2000
Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanomaJ M Kirkwood, R A Mascari, H D Edington, et al.
Molecular Medicine (Cambridge, Mass.)|March 11, 1999
Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesionsJ M Kirkwood, D L Farkas, A Chakraborty, et al.
Pageof 4